Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07487246 · ClinicalTrials.gov registry record · Phase 2
Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement
A Phase 2 study, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 76
- Enrollment target
NCT07487246: Recruiting Phase 2 study, sponsored by Rush University Medical Center.
NCT07487246 is a Phase 2 study that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 76 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07487246, a Phase 2 study, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to improve pain management for participantswho need osmotic dilators for cervical preparation the day before their second trimester abortion procedure.
Primary Outcome
i. Mean difference between arms in NRS immediately after insertion of osmotic dilators
Interventions
- DRUG Placebo
- DRUG Ketorolac
- DRUG Saline
- DRUG oral ibuprofen
- DRUG Lidocaine HCl 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2026-06-29 |
| Est. Completion | 2027-04-30 |
| Phase | Phase 2 |
What NCT07487246 shows while recruiting
NCT07487246 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT07487246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07487246 about?
NCT07487246 is a clinical study titled "Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement". The purpose of this study is to improve pain management for participantswho need osmotic dilators for cervical preparation the day before their second trimester abortion procedure.
What is the current status of trial NCT07487246?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2026-06-29. Estimated completion is 2027-04-30.
What interventions are being tested in trial NCT07487246?
The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG), Saline (DRUG), oral ibuprofen (DRUG), Lidocaine HCl 1% (DRUG).
Who is sponsoring clinical trial NCT07487246?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07487246's enrollment target sits among peer trials
76 893rd of 2000 higher than 1,101 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI